Govt Job for M.Pharm, M.Sc at Institute of Nano Science and Technology

Institute of Nano Science and Technology (INST), Mohali (Punjab), an autonomous institution of Department of Science and Technology (DST), Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India.

INST started its activities on 3rd January 2013, the date on which its first Director was appointed.

Applications are invited from highly motivated and bright candidates for engagement of Project Associate-I in the research project funded by ‘DBT’, Government of India at Institute of Nano Science and Technology, Mohali.

Project Associate – I
Title of the Project : Understanding the Forces Involved in the Packing of Enzymes Inside the Bacterial Microcompartments for the Development of Novel Encapsulated Bio-Systems

Principal Investigator : Dr. Sharmistha Sinha, Scientist-E
Qualifications: Essential: M.S(Pharm.) / M.Pharm / M.Tech. / M.Sc / M.V.Sc Degree in Pharmaceutical Sciences (preferable specialization in pharmaceutics or Pharmacology)/Biological Science/Life Sciences/Biotechnology with NET / GATE / GPAT qualification.

Desirable : Experience in nano-formulations, Cell culture studies, Biophysical Chemistry,

Age limit : The upper age limit shall be 35 years as on 15.07.2021, which is relaxed up to 5 years in the case of candidates belonging to Schedule Castes/Schedule Tribes/, Physically Handicapped/Visually Handicapped and female applicants whereas 3 years in case of OBCs (Non-creamy layer candidates).

Salary : Rs. 31,000/- + 8% HRA (pm)
Project duration : Initially for one year and may be extended based on performance of the candidate.

General Terms and Conditions :
• The position is purely temporary and on contractual basis and renewable subject to satisfactory performance till the end of the project. The position is co-terminus with the project. Candidate selected for this position can also apply for the regular PhD program of INST provided they satisfy eligibility criteria.

• No TA/DA will be paid for attending the interview.
• Original documents of age proof/certificates/degrees/mark sheets and other testimonials must be presented along with the self-attested photocopies of these documents at the time of interview.

Only shortlisted candidates will be communicated through email for online interview and no other communication in this regard will be entertained.

Completed applications in the prescribed format as annexed should reach to the following address by 15.07.2021 by speed-post or via email attachment (complete one combined PDF) addressed to :

Dr. Sharmistha Sinha
Scientist-E
Institute of Nanoscience and Technology (INST), Mohali
Sector-81, Knowledge City, Sahibzada Ajit Singh Nagar,
Punjab,
Pin – 140306
Email: sinhas@inst.ac.in

Last date of Receipt of applications : 15th July 2021.

Related Posts

Dr Reddy’s delays semaglutide supplies due to API issue

MUMBAI: Dr Reddy’s Laboratories’ plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing…

India Tightens Rules On Alcohol-Containing Medicines

New rules on alcohol in medicine: The Centre has brought oral medicines containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml under Schedule H1 In…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue

India Tightens Rules On Alcohol-Containing Medicines

India Tightens Rules On Alcohol-Containing Medicines

One more held in spurious plasma racket; police say he supplied 12 boxes

One more held in spurious plasma racket; police say he supplied 12 boxes

Wegovy, Ozempic regain weight as Indian generics fall behind

Wegovy, Ozempic regain weight as Indian generics fall behind

Drug regulator orders fresh safety labels for five common antimicrobials

Drug regulator orders fresh safety labels for five common antimicrobials

Rajasthan recalls labour-inducing drug after quality test failure

Rajasthan recalls labour-inducing drug after quality test failure